Katrin Schröder Selected Research

NADPH Oxidases (NAD(P)H oxidase)

8/2022	Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML).
6/2022	NADPH Oxidases in Pain Processing.
6/2021	NOX1/NADPH oxidase is involved in the LPS-induced exacerbation of collagen-induced arthritis.
1/2021	NADPH Oxidases Are Required for Full Platelet Activation In Vitro and Thrombosis In Vivo but Dispensable for Plasma Coagulation and Hemostasis.
10/2020	Deletion of NoxO1 limits atherosclerosis development in female mice.
7/2020	The NADPH Oxidase Isoform 1 Contributes to Angiotensin II-Mediated DNA Damage in the Kidney.
7/2020	Author Correction: NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD.
1/2020	Chronic Ethanol Feeding in Mice Decreases Expression of Genes for Major Structural Bone Proteins in a Nox4-Independent Manner.
1/2020	NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD.
1/2019	NADPH oxidases in bone homeostasis and osteoporosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katrin Schröder Research Topics

Disease

9	Inflammation (Inflammations) 01/2021 - 09/2010
7	Atherosclerosis 10/2020 - 11/2006
6	Neuralgia (Stump Neuralgia) 06/2022 - 07/2012
5	Hypoxia (Hypoxemia) 01/2019 - 09/2009
5	Cardiovascular Diseases (Cardiovascular Disease) 12/2015 - 01/2008
4	Neoplasms (Cancer) 08/2022 - 02/2011
4	Pain (Aches) 06/2022 - 07/2012
4	Vascular Diseases (Vascular Disease) 07/2013 - 10/2008
3	Osteoporosis 01/2020 - 01/2015
3	Reperfusion Injury 01/2017 - 09/2010
3	Hypertrophy 03/2015 - 09/2010
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2022 - 03/2022
2	Hypertension (High Blood Pressure) 07/2020 - 01/2008
2	Chronic Obstructive Pulmonary Disease (COPD) 07/2020 - 01/2020
2	Emphysema 07/2020 - 01/2020
2	Sepsis (Septicemia) 01/2019 - 12/2014
2	Marfan Syndrome (Marfan's Syndrome) 01/2018 - 01/2016
2	Ascending Aorta Aneurysm 01/2018 - 01/2016
2	Vascular Calcification 01/2018 - 09/2014
2	Wounds and Injuries (Trauma) 04/2017 - 01/2016
2	Fibrosis (Cirrhosis) 01/2017 - 07/2012
2	Hyperlipidemias (Hyperlipidemia) 10/2008 - 11/2006
1	Myocardial Infarction 08/2021
1	Atrophy 08/2021
1	Weight Loss (Weight Reduction) 07/2021
1	Experimental Arthritis 06/2021
1	Asthma (Bronchial Asthma) 06/2021
1	Thrombosis (Thrombus) 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Neointima 01/2021
1	Carotid Artery Thrombosis 01/2021
1	Pulmonary Embolism 01/2021
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021
1	Cardiomegaly (Heart Hypertrophy) 01/2021
1	Vascular System Injuries 01/2021
1	Intracranial Vasospasm 01/2021
1	Necrosis 10/2020
1	Metabolic Bone Diseases (Osteopenia) 01/2020
1	Pulmonary Hypertension 01/2020
1	Carcinogenesis 10/2018
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2018
1	Retinal Neovascularization 01/2018
1	Colitis 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

24	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2022 - 01/2008
21	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2022 - 01/2008
5	Tamoxifen FDA LinkGeneric 01/2021 - 04/2012
4	Superoxides (Superoxide)IBA 06/2022 - 03/2013
4	NADPH Oxidase 4IBA 01/2021 - 01/2016
4	AntioxidantsIBA 10/2017 - 10/2010
3	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 06/2022 - 03/2013
3	CytokinesIBA 06/2021 - 01/2008
3	Hormones (Hormone)IBA 01/2021 - 09/2014
3	NADP (NADPH)IBA 01/2021 - 01/2008
3	Angiotensin IIIBA 07/2020 - 04/2012
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 09/2010
3	EnzymesIBA 10/2016 - 01/2008
2	Protein Isoforms (Isoforms)IBA 06/2022 - 02/2012
2	setanaxibIBA 03/2022 - 07/2012
2	CollagenIBA 01/2021 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 10/2008
2	SmokeIBA 01/2020 - 01/2008
2	LipidsIBA 01/2019 - 01/2008
2	Oxygen (Dioxygen)IBA 01/2018 - 09/2009
2	Messenger RNA (mRNA)IBA 12/2014 - 11/2006
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2014 - 01/2008
1	Therapeutic UsesIBA 08/2022
1	Cytotoxins (Cytolysins)IBA 03/2022
1	Citrate (si)-Synthase (Synthase, Citrate)IBA 08/2021
1	SodiumIBA 07/2021
1	EndotoxinsIBA 06/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	ferric chlorideIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Thrombin FDA Link 01/2021
1	Reactive Nitrogen SpeciesIBA 01/2021
1	Complementary DNA (cDNA)IBA 01/2021
1	NitrogenIBA 01/2021
1	CalciumIBA 10/2020
1	3-nitrotyrosineIBA 01/2020
1	NADPH Oxidase 2IBA 01/2020
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2020
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020
1	Epoxide HydrolasesIBA 01/2019
1	Pharmaceutical PreparationsIBA 10/2018
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	Phosphates (Orthophosphate)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Dextran SulfateIBA 01/2018
1	AzoxymethaneIBA 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	SphingosineIBA 01/2018
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2018

Therapy/Procedure

5	Ligation 01/2019 - 07/2012
3	Therapeutics 01/2021 - 10/2017
2	Punctures 01/2019 - 12/2014
2	Orthopedic Procedures 04/2017 - 01/2016
1	Lasers (Laser) 01/2021
1	Precision Medicine 10/2018